Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone

Stopped Study reached halfway point in approximately one year time period and was halted to analyze data.

Conditions

• Multiple Sclerosis

Interventions

• DRUG: Methylprednisolone
• DRUG: ACTH
• OTHER: IV placebo
• OTHER: IM placebo

Sponsor

Neurologique Foundation, Inc.

Collaborators

• [object Object]